- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 173.67M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.12B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.12B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $21.85M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $21.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $171.99M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $168.69M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.28B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.31B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $241M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $250.69M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.59B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.62B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $471.8M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $475.99M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.87B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.92B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 143.59M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $321K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $38.33M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $40.66M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $12.47M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.91M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$726K |
| Revenue | Q1 2025 · Mar 31, 2024 | $169.42M |